Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEland Oil & Gas Regulatory News (ELA)

  • There is currently no data for ELA

RBL Facility Update

6 Apr 2018 07:00

RNS Number : 0415K
Eland Oil & Gas PLC
06 April 2018
 

6 April 2018

 

Eland Oil & Gas PLC

("Eland" or the "Company")

 

RBL Facility Update

 

Eland Oil & Gas PLC (AIM: ELA), an oil & gas production and development company operating in West Africa with an initial focus on Nigeria, is pleased to announce the following update on its Reserve Based Lending ("RBL") facility.

 

Following the successful infill drilling of Opuama-8 the Company has reprofiled its RBL facility with its lenders, Standard Chartered Bank, The Mauritius Commercial Bank Ltd and Mercuria Energy Trading S.A. The facility amount remains at $35million but the initial borrowing base amount has increased from $40 million to $70.1 million based on only Opuama-1, -3, -7 and -8 production and cash flows. Of the available facility, $27 million is currently drawn.

 

The RBL facility has been amended and restated with the same maturity of 30 June 2019, however, principal repayments will now not commence until March 2019. All other terms of the facility remain the same. Funds will continue to be conservatively used, along with the regular cash inflows from Opuama production, to support the funding of the remaining Opuama infill wells, growing Opuama's production to over 30,000bopd in H1 2018, as well as supporting the development of other Company assets.

 

The Group's current cash position is $35.6 million.

 

Ronald Bain, CFO of Eland, commented:

"The exceptional increase in headroom, which equates to the size of the existing facility, from the introduction of the Opuama-8 well shows the hugely accretive quality of each new well drilled on the OML 40 asset and the significant growth in value they bring to stakeholders. The Company continues its preparations to refinance the RBL in 2018 into a longer-term facility based on Opuama's full production potential and future OML 40 development."

 

Ends

 

For further information:

 

Eland Oil & Gas PLC (+44 (0)1224 737300)

LEI: 213800QDGQKG3JKKRR86

www.elandoilandgas.com

George Maxwell, CEO

Ronald Bain, CFO

Finlay Thomson, IR

 

Canaccord Genuity Limited (+44 (0)20 7523 8000)

Henry Fitzgerald O'Connor / James Asensio

 

Panmure Gordon (UK) Limited (+44 (0)20 7886 2500)

Adam James / Atholl Tweedie

Tom Salvesen

 

Camarco (+44 (0) 203 757 4980)

Billy Clegg / Georgia Edmonds / Tom Huddart

 

Notes to editors:

Eland Oil & Gas is an AIM-listed independent oil and gas company focused on production and development in West Africa, particularly the highly prolific Niger Delta region of Nigeria.

Through its joint venture company Elcrest, Eland's core asset is OML 40 which is located in the Northwest Niger Delta approximately 75km northwest of Warri and has an area of 498km². In addition, the Company has a 40% interest in the Ubima Field, onshore Niger Delta, in the northern part of Rivers State.

The OML 40 licence holds gross 2P reserves of 83.2 mmbbls, gross 2C contingent resources of 41.2 mmbbls and a best estimate of 254.5 mmbbls of gross unrisked prospective resources. The Ubima field holds gross 2P reserves of 2.4 mmbbls of oil and gross 2C resource estimates of 31.1 mmbbl.

Net production figures relate to Elcrest Exploration and Production Nigeria Ltd ("Elcrest"), Eland's joint venture company. Production rates, are as measured at the Opuama PD meter, are subject to reconciliation and will differ from sales volumes.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDUGUCCCUPRPPA
Date   Source Headline
7th Jan 200810:30 amRNSHolding in Company
2nd Jan 20085:08 pmRNSHolding in Company
2nd Jan 20082:45 pmRNSHolding in Company
31st Dec 200710:23 amRNSTotal Voting Rights
19th Dec 20074:45 pmRNSBlocklisting Interim Review
7th Dec 20079:13 amRNSHolding in Company
6th Dec 20073:12 pmRNSHolding in Company
4th Dec 20075:01 pmRNSDirector/PDMR Shareholding
30th Nov 200712:47 pmRNSTotal Voting Rights
28th Nov 20075:44 pmRNSDirector/PDMR Shareholding
9th Nov 20079:58 amRNSHolding in Company
7th Nov 20074:52 pmRNSDirector/PDMR Shareholding
31st Oct 200712:21 pmRNSTotal Voting Rights
30th Oct 200712:28 pmRNSDirector/PDMR Shareholding
3rd Oct 20076:29 pmRNSHolding in Company
28th Sep 200712:52 pmRNSTotal Voting Rights
25th Sep 20073:21 pmRNSHolding and Company
21st Sep 20074:50 pmRNSNew Board Appointments
20th Sep 20074:49 pmRNSDirector/PDMR Shareholding
20th Sep 20072:44 pmRNSDirector/ PDMR Shareholding
18th Sep 20076:16 pmRNSHolding in Company
14th Sep 200712:54 pmRNSDirector/PDMR Shareholding
7th Sep 20078:22 amRNSInterim Financial Statements
7th Sep 20077:30 amRNSTreasury Shares Cancelled
31st Aug 200712:17 pmRNSTotal Voting Rights
2nd Aug 20075:39 pmRNSHolding in Company
2nd Aug 20072:37 pmRNSHolding in Company
1st Aug 20072:49 pmRNSDirector PDMR Shareholding
31st Jul 20072:09 pmRNSTotal Voting Rights
19th Jul 200711:48 amRNSHolding in Company
6th Jul 20073:30 pmRNSDirectors Disclosure
29th Jun 20072:55 pmRNSTotal Voting Rights
26th Jun 20073:46 pmRNSHolding in Company
13th Jun 20073:40 pmRNSBlocklisting Interim Review
14th May 20073:14 pmRNSHolding in Company
30th Apr 20074:37 pmRNSDirectors/PDMR Shareholding
30th Apr 20079:41 amRNSAnnual Information Document
24th Apr 200710:06 amRNSDirector/PDMR Shareholding
14th Mar 20071:52 pmRNSDirector/PDMR Shareholding
13th Mar 200712:47 pmRNSDirectors/PDMR Shareholding
6th Mar 20073:15 pmRNSStatement re Drug License
1st Mar 200710:35 amRNSDirector/PDMR Shareholding
23rd Feb 20075:13 pmRNSDirector/PDMR Shareholding
22nd Feb 20076:00 pmRNSDirectors/PDMR Shareholding
7th Feb 200711:13 amRNSHolding in Company
21st Dec 200611:23 amRNSBrochure of Particulars
19th Dec 20066:05 pmRNSDirectorate Change
23rd Nov 20064:21 pmRNSDirector/PDMR Shareholding
17th Nov 20064:32 pmRNSBrochure of Particulars
15th Nov 20062:51 pmRNSAnnual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.